Exocrine Pancreatic Insufficiency Therapeutics Market to reach USD 2.55 Billion by 2026; Rising Prevalence of Severe Chronic Disorders to Favour Growth: Fortune Business Insights Pune, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The global Exocrine Pancreatic Insufficiency Therapeutics Market to reach USD 2.55 billion by 2026, exhibiting a CAGR of 6.5% during the forecast period....